private:criticalpharmaceuticals
|
99668
|
Feb 17th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 16th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 15th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 14th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 13th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 12th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 11th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 10th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 9th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|
private:criticalpharmaceuticals
|
99668
|
Feb 8th, 2018 12:00AM
|
Critical Pharmaceuticals Ltd.
|
807
|
8.00
|
Open
|
Biotechnology
|
Feb 8th, 2017 11:57AM
|
Feb 8th, 2017 11:57AM
|
Critical Pharmaceuticals is a Nottingham UK-based biotechnology company developing a pipeline of unique biological drug products utilising its proprietary drug delivery technologies. Critical Pharmaceuticals lead product is a nasal formulation of human growth hormone in Phase 1 clinical development that is expected to have significant advantages of existing daily injectable products. In addition, we partner our proprietary drug delivery technologies with other biopharmaceutical companies to develop long acting injectable products and nasal delivery of proteins, peptides and labile or insoluble small molecules. CriticalMix is an novel encapsulation technology that produces injectable biodegradable microparticles able to sustain drug release over weeks to months. CriticalMix is entirely solvent free and operates at near ambient temperatures, and therefore preserves protein structure and integrity. CriticalSorb is a novel absorption promoter able to achieve exceptionally high bioavailabilities of nasally administered proteins, opening up the possibility of developing nasal sprays as a direct replacement for injections.
|
|
|
|
|
|
|
|
|
|
Critical Pharmaceuticals
|
|
Pharmaceuticals & Biotechnology
|